Abstract
THE ability of prostaglandins to affect platelet function has been described in many laboratories1,2. The most potent of these, prostaglandin E1 (PGE1), has been found to inhibit platelet aggregation and stimulate platelet adenyl cyclase. The effect of prostaglandin E2 (PGE2), however, has been either inhibitory or stimulatory, depending both upon the species of animal examined3 and the concentration of prostaglandin used4.
Similar content being viewed by others
References
Ball, G., Brereton, G. G., Fulwood, M., Ireland, D. M., and Yates, P., Biochem. J., 120, 709–718 (1970).
Mills, D. C. B., and Smith, J. B., Biochem. J., 121, 185–196 (1971).
Kloeze, J., in Prostaglandins (edit. by Bergstrom, S. and Samuelsson, B.) 241–252 (Almquist and Wiksell, Stockholm, 1967).
Salzman, E. W., New Engl. J. Med., 286, 358–363 (1972).
Smith, J. B., and Willis, A. L., Nature new Biol., 231, 235–237 (1971).
Droller, M. J., Proc. 15th Mtg Am. Soc. Hematol. (1972).
Born, G. V. R., J. Physiol., Lond., 162, 67P–68P (1962).
Hirsh, J., Street, D., Cade, J. F., and Amy, H., Blood, 41, 369–377 (1973).
Haslam, R. J., Nature, 202, 765–768 (1964).
Wolfe, S. M., and Shulman, N. R., Biochem. biophys. Res. Commun., 35, 265–272 (1969).
White, A. A., and Zenser, T. V., Analyt. Biochem., 41, 372–396 (1971).
Ramachandran, J., Analyt. Biochem., 43, 227–239 (1971).
Droller, M. J., and Wolfe, S. M., J. clin. Invest., 51, 3094–3103 (1972).
Shio, H., and Ramwell, P. W., Nature new Biol., 236, 45–46 (1972).
Droller, M. J., and Wolfe, S. M., New Engl. J. Med., 286, 948 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BRUNO, J., TAYLOR, L. & DROLLER, M. Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation. Nature 251, 721–723 (1974). https://doi.org/10.1038/251721a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/251721a0
- Springer Nature Limited